相似文献
1
Rise and fall of Caspofungin: the current status of Caspofungin as a treatment for infection.
Future Microbiol. 2024;19(7):621-630. doi: 10.2217/fmb-2023-0236. Epub 2024 Mar 18.
2
Lipid Flippase Subunit Cdc50 Mediates Drug Resistance and Virulence in Cryptococcus neoformans.
mBio. 2016 May 10;7(3):e00478-16. doi: 10.1128/mBio.00478-16.
3
Development of Antifungal Peptides against Cryptococcus neoformans; Leveraging Knowledge about the Mutant Susceptibility for Lead Compound Development.
Microbiol Spectr. 2022 Apr 27;10(2):e0043922. doi: 10.1128/spectrum.00439-22. Epub 2022 Apr 4.
4
A Mechanosensitive Channel Governs Lipid Flippase-Mediated Echinocandin Resistance in Cryptococcus neoformans.
mBio. 2019 Dec 10;10(6):e01952-19. doi: 10.1128/mBio.01952-19.
5
Puf4 Mediates Post-transcriptional Regulation of Cell Wall Biosynthesis and Caspofungin Resistance in Cryptococcus neoformans.
mBio. 2021 Jan 12;12(1):e03225-20. doi: 10.1128/mBio.03225-20.
6
Unraveling Caspofungin Resistance in Cryptococcus neoformans.
mBio. 2021 Mar 16;12(2):e00156-21. doi: 10.1128/mBio.00156-21.
7
Brilacidin, a novel antifungal agent against .
mBio. 2024 Jul 17;15(7):e0103124. doi: 10.1128/mbio.01031-24. Epub 2024 Jun 25.
8
Cryptococcus neoformans resistance to echinocandins: (1,3)beta-glucan synthase activity is sensitive to echinocandins.
Antimicrob Agents Chemother. 2005 Jul;49(7):2851-6. doi: 10.1128/AAC.49.7.2851-2856.2005.
9
Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
Antimicrob Agents Chemother. 2017 Feb 23;61(3). doi: 10.1128/AAC.02045-16. Print 2017 Mar.
10
Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin.
Antimicrob Agents Chemother. 2002 Nov;46(11):3394-400. doi: 10.1128/AAC.46.11.3394-3400.2002.
引用本文的文献
1
Toxicity Assessment and Antifungal Potential of Copper(II) and Silver(I) Complexes with 1,10-Phenanthroline-5,6-dione Against Drug-Resistant Clinical Isolates of and .
J Fungi (Basel). 2025 Jun 6;11(6):436. doi: 10.3390/jof11060436.
2
Effects of the Tobacco Defensin NaD1 Against Susceptible and Resistant Strains of .
Pathogens. 2024 Dec 10;13(12):1092. doi: 10.3390/pathogens13121092.
本文引用的文献
1
Exposure of to Seven Commonly Used Agricultural Azole Fungicides Induces Resistance to Fluconazole as Well as Cross-Resistance to Voriconazole, Posaconazole, Itraconazole and Isavuconazole.
Pathogens. 2023 Apr 29;12(5):662. doi: 10.3390/pathogens12050662.
2
A host defense peptide mimetic, brilacidin, potentiates caspofungin antifungal activity against human pathogenic fungi.
Nat Commun. 2023 Apr 12;14(1):2052. doi: 10.1038/s41467-023-37573-y.
3
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial.
Lancet. 2023 Jan 7;401(10370):49-59. doi: 10.1016/S0140-6736(22)02324-8. Epub 2022 Nov 25.
4
The molecular and genetic basis of antifungal resistance in the emerging fungal pathogen Candida auris.
Curr Opin Microbiol. 2022 Dec;70:102208. doi: 10.1016/j.mib.2022.102208. Epub 2022 Oct 12.
5
Membrane Integrity Contributes to Resistance of Cryptococcus neoformans to the Cell Wall Inhibitor Caspofungin.
mSphere. 2022 Aug 31;7(4):e0013422. doi: 10.1128/msphere.00134-22. Epub 2022 Jun 27.
6
Efficacy and safety of caspofungin for patients with hepatic insufficiency.
BMC Infect Dis. 2022 Jun 20;22(1):560. doi: 10.1186/s12879-022-07527-8.
7
Development of Antifungal Peptides against Cryptococcus neoformans; Leveraging Knowledge about the Mutant Susceptibility for Lead Compound Development.
Microbiol Spectr. 2022 Apr 27;10(2):e0043922. doi: 10.1128/spectrum.00439-22. Epub 2022 Apr 4.
8
Caspofungin resistance in Candida albicans: genetic factors and synergistic compounds for combination therapies.
Braz J Microbiol. 2022 Sep;53(3):1101-1113. doi: 10.1007/s42770-022-00739-9. Epub 2022 Mar 29.
9
Echinocandins - structure, mechanism of action and use in antifungal therapy.
J Enzyme Inhib Med Chem. 2022 Dec;37(1):876-894. doi: 10.1080/14756366.2022.2050224.
10
Green synthesis of selenium nanoparticles and evaluate their effect on the expression of ERG3, ERG11 and FKS1 antifungal resistance genes in Candida albicans and Candida glabrata.
Lett Appl Microbiol. 2022 May;74(5):809-819. doi: 10.1111/lam.13667. Epub 2022 Mar 6.
Zotero 插件